Pulmozyme in Cystic Fibrosis With Sinusitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2015

Conditions
SinusitisCystic Fibrosis
Interventions
DRUG

Pulmozyme single use ampule

• Each Pulmozyme single use ampule delivers 2.5 mL (2.5 mg) of the sterile solution to the nebulizer bowl. The aqueous solution contains 1.0 mg/mL dornase alfa, 0.15 mg/mL calcium chloride dihydrate, and 8.77 mg/mL sodium chloride.

DRUG

placebo

identical placebo

Trial Locations (1)

17033

Penn State Unicersity, Hershey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Milton S. Hershey Medical Center

OTHER